FDA Panel Concludes Pfizer Vaccine Hearing

FDA Panel Concludes Pfizer Vaccine Hearing

(ConservativeHub.com) – The nation anxiously awaits the Food and Drug Administration (FDA) rulings on two separate applications for an Emergency Use Authorization (EUA) for COVID-19 vaccines. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met with officials from Pfizer/BioNTech for a day-long hearing regarding their application on December 10.

Scientists working for the FDA already endorsed the Pfizer vaccine’s effectiveness and safety in a December 8 report. The VRBPAC is widely expected to recommend approval for the EUA.

Although there is currently no deadline for the VRBPAC’s submission, the FDA will likely accept the committee’s recommendation. Upon approval of the EUA, the vaccine can begin rolling out to the states within a few days.

The FDA set up an online sheet for public comments regarding the meeting. Its electronic filing system is located at http://www.regulations.gov/, and the docket number assigned to the Pfizer application is FDA-2020-N-2242. Comments close on December 16 at 11:59 PM. Paper submissions can be sent to Dockets Management Staff (HFA), FDA, 5630 Fishers Lane, Room 1061, Rockville, Maryland 20852.

Copyright 2020, ConservativeHub.com